Bibliografias temáticas / Lysosomal storage diseases

Índice

  1. Artigos de revistas
  2. Teses / dissertações
  3. Livros
  4. Capítulos de livros
  5. Trabalhos de conferências

Literatura científica selecionada sobre o tema "Lysosomal storage diseases"

Autor: Grafiati
Publicado: 4 de junho de 2021
Última modificação: 25 de julho de 2025

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Lysosomal storage diseases".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Artigos de revistas sobre o assunto "Lysosomal storage diseases"

1

Xu, Miao, Ke Liu, Manju Swaroop, et al. "A Phenotypic Compound Screening Assay for Lysosomal Storage Diseases." Journal of Biomolecular Screening 19, no. 1 (2013): 168–75. http://dx.doi.org/10.1177/1087057113501197.

Texto completo da fonte
Resumo:
The lysosome is a vital cellular organelle that primarily functions as a recycling center for breaking down unwanted macromolecules through a series of hydrolases. Functional deficiencies in lysosomal proteins due to genetic mutations have been found in more than 50 lysosomal storage diseases that exhibit characteristic lipid/macromolecule accumulation and enlarged lysosomes. Recently, the lysosome has emerged as a new therapeutic target for drug development for the treatment of lysosomal storage diseases. However, a suitable assay for compound screening against the diseased lysosomes is curre
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Schulze, M., S. Groeschel, J. Gburek-Augustat, T. Nägele, and M. Horger. "Lysosomal Storage Diseases – Lysosomale Speichererkrankungen." RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 187, no. 12 (2015): 1057–60. http://dx.doi.org/10.1055/s-0035-1552368.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Simonaro, Calogera M. "Lysosomes, Lysosomal Storage Diseases, and Inflammation." Journal of Inborn Errors of Metabolism and Screening 4 (May 14, 2016): 232640981665046. http://dx.doi.org/10.1177/2326409816650465.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Breiden, Bernadette, and Konrad Sandhoff. "Lysosomal Glycosphingolipid Storage Diseases." Annual Review of Biochemistry 88, no. 1 (2019): 461–85. http://dx.doi.org/10.1146/annurev-biochem-013118-111518.

Texto completo da fonte
Resumo:
Glycosphingolipids are cell-type-specific components of the outer leaflet of mammalian plasma membranes. Gangliosides, sialic acid–containing glycosphingolipids, are especially enriched on neuronal surfaces. As amphi-philic molecules, they comprise a hydrophilic oligosaccharide chain attached to a hydrophobic membrane anchor, ceramide. Whereas glycosphingolipid formation is catalyzed by membrane-bound enzymes along the secretory pathway, degradation takes place at the surface of intralysosomal vesicles of late endosomes and lysosomes catalyzed in a stepwise fashion by soluble hydrolases and as
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Gorbunova, Victoria N. "Congenital metabolic diseases. Lysosomal storage diseases." Pediatrician (St. Petersburg) 12, no. 2 (2021): 73–83. http://dx.doi.org/10.17816/ped12273-83.

Texto completo da fonte
Resumo:
The classification and epidemiology of hereditary metabolic disorders are presented. That is a large group consisting from more them 800 monogenic diseases, each of which caused by inherited deficiency of certain metabolic fate. Many of these disorders are extremely rare, but their total incidence in the population is close to 1:10005000. Lysosomal storage diseases (LSD) resulting from inherited deficiency in lysosomal functions occupy a special place among hereditary metabolic disorders. The defects of catabolism cause the accumulation of undigested or partially digested macromolecules in lys
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Gorbunova, Viktoria N., Natalia V. Buchinskaia, and Anastasia O. Vechkasova. "Lysosomal storage diseases. Mucolipidosis." Pediatrician (St. Petersburg) 15, no. 5 (2024): 81–98. https://doi.org/10.17816/ped15581-98.

Texto completo da fonte
Resumo:
The epidemiology, clinical, biochemical and molecular genetic characteristics of mucolipidoses — autosomal recessive lysosomal storage diseases that combine the clinical manifestations of mucopolysaccharidoses and sphingolipidoses — are presented. In accordance with the modern classification, types I, II and III mucolipidoses are classified as glycoproteinoses, and type IV mucolipidoses are classified as gangliosidoses. Mucolipidoses type I, or sialidosis, is caused by the presence of inactivating mutations in the α-neuraminidase gene NEU1, and a related disease is galactosialidosis, accompani
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Gorbunova, Victoria N., Natalia V. Buchinskaia, and Anastasia O. Vechkasova. "Lysosomal storage diseases. Glycoproteinoses — oligosaccharidoses." Pediatrician (St. Petersburg) 16, no. 1 (2025): 5–24. https://doi.org/10.17816/ped1615-24.

Texto completo da fonte
Resumo:
The epidemiology, clinical, biochemical and molecular genetic characteristics of oligosaccharidoses are presented — a group of rare autosomal recessive lysosomal diseases, includes sialidosis, mannosidosis, fucosidosis, aspartylglucosaminuria and α-N-acetylgalactosaminidase deficiency. All these diseases are caused by impaired catabolism of glycoproteins and excessive accumulation of various types of oligosaccharides in lysosomes. Clinically, they are characterized by progressive neuropsychiatric disorders combined with a mild gurler-like phenotype. Two genetically heterogeneous variants of al
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Ferreira, Carlos R., and William A. Gahl. "Lysosomal storage diseases." Translational Science of Rare Diseases 2, no. 1-2 (2017): 1–71. http://dx.doi.org/10.3233/trd-160005.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Rose Georgy, Smitha. "Lysosomal storage diseases." Journal of Veterinary and Animal Sciences 52, no. 1 (2021): 1–6. http://dx.doi.org/10.51966/jvas.2021.52.1.1-6.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Neufeld, Elizabeth F. "Lysosomal Storage Diseases." Annual Review of Biochemistry 60, no. 1 (1991): 257–80. http://dx.doi.org/10.1146/annurev.bi.60.070191.001353.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Teses / dissertações sobre o assunto "Lysosomal storage diseases"

1

Roy, Elise. "Cell disorders in lysosomal storage diseases." Phd thesis, Université René Descartes - Paris V, 2012. http://tel.archives-ouvertes.fr/tel-00683248.

Texto completo da fonte
Resumo:
Mucopolysaccharidosis type IIIB (MPSIIIB) is a lysosomal storage disease (LSD) characterized by accumulation of heparan sulfate oligosaccharides (HSO), which results in progressive mental retardation, neurodegeneration and premature death in children. The underlying mechanisms are poorly understood. Coming to a better understanding of the pathophysiology of MPSIIIB has become a necessity to assess the efficacy of gene therapy treatment regarding loss of neuronal plasticity, and to define the best conditions for treatment. To address the link between HSO accumulation and downstream pathological
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Chen, Chun-Wu. "Defective iron homeostasis in lysosomal storage diseases." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:5127c241-be64-4990-bef5-70e15d391394.

Texto completo da fonte
Resumo:
Niemann-Pick type Cl (NPC1) disease is a neurodegenerative lysosomal storage disorder characterized by the accumulation of multiple lipids in the late endosome/lysosomal system and reduced acidic store calcium levels. Since the lysosomal system is involved in regulating aspects of transition metal ion homeostasis and its intracellular compartmentalization, we have investigated whether there are metal ion metabolism defects and haematological abnormalities in NPC1 disease. We have identified multiple haematological changes, including decreased haematocrit, haemoglobin and mean corpuscular haemo
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Ross, Colin J. D. "Immuno-isolation gene therapy for lysosomal storage disease /." *McMaster only, 2001.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Rigal, Nathalie [Verfasser]. "Improving enzyme replacement therapy for lysosomal storage diseases / Nathalie Rigal." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2018. http://d-nb.info/115576093X/34.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Lewis, Martin David. "Human lysosomal sulphate transport." Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phl6752.pdf.

Texto completo da fonte
Resumo:
Addendum inserted at back Includes bibliographical references (leaves 266-287). 1. Introduction -- 2. Materials and general methods -- 3. Characterisation and partial purification of the lysosomal sulphate transporter -- 4. Identification of proteins involved in lysosomal sulphate transport -- 5. The relationship between a sulphate anion transporter family and the lysosomal sulphate transporter -- 6. Investigation of sulphate transport in human skin fibroblasts -- 7. Concluding remarks
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Kanju, Patrick M. Suppiramaniam Vishnu. "Synaptic glutamate receptor dysfunction in tissue and animal models of Alzheimer's disease." Auburn, Ala., 2005. http://repo.lib.auburn.edu/2005%20Summer/doctoral/KANJU_PATRICK_11.pdf.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Champigny, Marc J. Igdoura Suleiman. "Transcriptional regulation of neu1 expression: Implications for lysosomal storage disease /." *McMaster only, 2005.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Maalouf, Katia Ghandour [Verfasser]. "Role of lipid rafts in the pathophysiology of lysosomal storage diseases / Katia Ghandour Maalouf." Hannover : Technische Informationsbibliothek und Universitätsbibliothek Hannover (TIB), 2012. http://nbn-resolving.de/urn:nbn:de:gbv:089-7259318337.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Ghandour, Maalouf Katia [Verfasser]. "Role of lipid rafts in the pathophysiology of lysosomal storage diseases / Katia Ghandour Maalouf." Hannover : Technische Informationsbibliothek und Universitätsbibliothek Hannover (TIB), 2012. http://d-nb.info/1029515352/34.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Gray, James Andrew Russell. "Modulating the heat-shock response : a potential therapy for lysosomal storage disorders." Thesis, University of Oxford, 2014. https://ora.ox.ac.uk/objects/uuid:d9b746c9-9026-4a6e-97b5-00bb848100d7.

Texto completo da fonte
Resumo:
Lysosomal storage disorders (LSDs) comprise a broad disease group of inherited metabolic disorders, the majority of which are associated with CNS pathology, significant disability and reductions in life expectancy. LSDs are caused by mutations in genes encoding proteins critical for the correct functioning of lysosomal homeostasis. The disruption of lysosomal homeostasis results in the abnormal accumulation of lysosomal content, initiating intracellular pathological events, including calcium dysregulation and lysosomal membrane permeablisation (LMP) affecting cell function and inducing cellula
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Livros sobre o assunto "Lysosomal storage diseases"

1

A, Barranger John, and Cabrera-Salazar Mario A, eds. Lysosomal storage disorders. Springer, 2007.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Mehta, Atul B., and Bryan Winchester. Lysosomal storage disorders: A practical guide. Wiley-Blackwell, 2013.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Mononen, Ilkka. Lysosomal storage disease--aspartylglycosaminuria. Springer, 1997.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Inc, ebrary, ed. Lysosomal storage disorders: Principles and practice. World Scientific, 2010.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Boelens, Jaap Jan, and Robert Wynn, eds. Stem Cell Therapy in Lysosomal Storage Diseases. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8357-1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

A, Gibbs Dorothy, ed. Lysosomal storage diseases: Biochemical and clinical aspects. Taylor & Francis, 1986.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

G, Thoene Jess, ed. Pathophysiology of lysosomal transport. CRC Press, 1992.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Al-Essa, Mohammed A. Atlas of common lysosomal and peroxisomal disorders. Scientific Informations Office, Research Centre, King Faisal Specialist Hospital and Research Centre, 1999.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Beck, M., Deborah Elstein, and Gheona Altarescu. Fabry disease. Springer, 2010.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

1935-, Graucob E., ed. Hematologic cytology of storage diseases. Springer-Verlag, 1985.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Capítulos de livros sobre o assunto "Lysosomal storage diseases"

1

Ozand, Pinar T., and Mohammed Al-Essa. "Lysosomal Storage Diseases." In Textbook of Clinical Pediatrics. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_39.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Ferns, Janis M., and Stephen H. Halpern. "Lysosomal Storage Diseases." In Consults in Obstetric Anesthesiology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-59680-8_98.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Pastores, Gregory M. "Lysosomal Storage Diseases." In Neurochemical Mechanisms in Disease. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7104-3_23.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Imam, Ibrahim. "Lysosomal storage diseases." In 700 Essential Neurology Checklists. CRC Press, 2021. http://dx.doi.org/10.1201/9781003221258-99.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Winchester, Bryan. "Classification of Lysosomal Storage Diseases." In Lysosomal Storage Disorders. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118514672.ch5.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

O'Rourke, Erin, Dawn Laney, Cindy Morgan, Kim Mooney, and Jennifer Sullivan. "Genetic Counseling for Lysosomal Storage Diseases." In Lysosomal Storage Disorders. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_13.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Kent, Alastair, Christine Lavery, and Jeremy Manuel. "The Patient Perspective on Rare Diseases." In Lysosomal Storage Disorders. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118514672.ch24.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Winchester, Bryan. "Laboratory Diagnosis of Lysosomal Storage Diseases." In Lysosomal Storage Disorders. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118514672.ch3.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Brady, Roscoe O. "The Concept of Treatment in Lysosomal Storage Diseases." In Lysosomal Storage Disorders. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_3.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

de Duve, Christian. "From Lysosomes to Storage Diseases and Back: A Personal Reminiscence." In Lysosomal Storage Disorders. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Trabalhos de conferências sobre o assunto "Lysosomal storage diseases"

1

Giugliano, Giusy, Michela Schiavo, Daniele Pirone, et al. "Investigation on lysosomal accumulation by a quantitative analysis of 2D phase-maps in digital holography microscopy." In Digital Holography and Three-Dimensional Imaging. Optica Publishing Group, 2024. http://dx.doi.org/10.1364/dh.2024.th2a.6.

Texto completo da fonte
Resumo:
Quantitative Phase Imaging through Digital Holography (QPI-DH) represents a quantitative and label-free method to detect lysosomal dysfunction in cells. Testing in the cellular model of Mucopolysaccharidosis type III-A, a lysosomal storage disease, demonstrate its potential.
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Krželj, Vjekoslav, and Ivana Čulo Čagalj. "INHERITED METABOLIC DISORDERS AND HEART DISEASES." In Symposium with International Participation HEART AND … Akademija nauka i umjetnosti Bosne i Hercegovine, 2019. http://dx.doi.org/10.5644/pi2019.181.02.

Texto completo da fonte
Resumo:
Inherited metabolic disorders can cause heart diseases, cardiomyopathy in particular, as well as cardiac arrhythmias, valvular and coronary diseases. More than 40 different inherited metabolic disorders can provoke cardiomyopathy, including lysosomal storage disorders, fatty acid oxidation defects, organic acidemias, amino acidopathies, glycogen storage diseases, congenital disorders of glycosylation as well as peroxisomal and mitochondrial disorders. If identified and diagnosed on time, some of congenital metabolic diseases could be successfully treated. It is important to assume them in case
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Medina, Diego. "Combining high-content imaging and repurposing of approved drugs to tackle lysosomal storage diseases." In Optical Methods for Inspection, Characterization, and Imaging of Biomaterials VI, edited by Pietro Ferraro, Simonetta Grilli, and Demetri Psaltis. SPIE, 2023. http://dx.doi.org/10.1117/12.2675267.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Alblooshi, Afaf, Abdul-Kader Souid, and Fatma Al Jasmi. "The Usefulness of Forced Oscillation Technique to assess lung functions in Patients with Lysosomal Storage Diseases." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2413.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Decker, Christine, Katharina Kranz, Kristine Adam, Charlotte Thiels, Cornelia Köhler, and Thomas Lücke. "P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses." In Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1676012.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Guimarães, Matheus Procópio, Isabella Cristina Muniz Honorato, Diógenes Emanuel Dantas da Silva, et al. "A 26-year-old woman presenting with a history of epileptic crisis, ataxia and cognitive impairment." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.645.

Texto completo da fonte
Resumo:
A 26-year-old woman was referred to a neurology outpatient clinic due to a 9-month history of generalized tonic-clonic seizures, gradually more frequent since onset. She additionally reports developing insidiously over four years ago, an asymmetrical tremor in the upper limbs (worse on the right hand), difficulty walking, speech disorders and decreased visual acuity on the right eye. She had a past medical history of major depressive disorder, but normal neuropsychomotor development in childhood, and did not drink alcohol or smoke tobacco. There is no family history of neurological conditions
Estilos ABNT, Harvard, Vancouver, APA, etc.
Você também pode estar interessado nas extensas listas de trabalhos sobre o assunto "Lysosomal storage diseases":
Artigos de revistas Teses / dissertações Livros
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!

Vá para a bibliografia